Placenta Accreta Spectrum: Prevalence, Trend and Association with Sociodemographic/Obstetric Factors in a Tertiary Health Facility in Niger Delta, Nigeria https://doi.org/10.60787/NMJ-63-6-160
Main Article Content
Keywords
Morbidly adherent placenta, Placenta Praevia, Accreta, Increta, Percreta, Haemorrhage, RSU
Abstract
Background: Placenta accreta spectrum (PAS) describes the abnormal adherence of the placenta trophoblast to the myometrium and is associated with high foetal-maternal morbidity and mortality. This study was aimed at determining the prevalence and trend of placenta accreta spectrum (PAS), as well as its association with sociodemographic/obstetrics factors at the Rivers State University Teaching Hospital (RSUTH).
Methodology: An analytical cross-sectional study of all recorded cases of placenta accreta spectrum managed at RSUTH from 1st January 2016 to 31st December 2021. Descriptive and inferential statistics were derived using IBM, Statistical Product and Service Solution (SPSS) version 25.0 Armonk, NY.
Results: There were 14195 deliveries, 137 cases of placenta praevia and 39 cases of placenta accreta spectrum. The prevalence of PAS at the RSUTH was 0.27% or 2.7 /1000 deliveries or 1in 370 deliveries. The rate of PAS among cases of placenta praevia was 28.5% or 1 in 4 cases. More than half of the variants of PAS were accreta, 23 (59.0%), while 13(33.3%) and 3(7.7%) were increta and percreta, respectively. The mean (SD) age and gestational age of the participants were 32.28 (± 5.13), [95% Confidence Interval (CI): 30.63, 33.92] and 36.43(±2.01), (95%CI: 35.18, 37.07) respectively. The modal age group was 35-39 years. The median blood loss was 650mls range of 450-2000mls. The majority of the study participants were booked, 34(87.2%) and had secondary level education, 17(43.6%). History of a previous caesarean section was statistically significantly associated with PAS P<0.001, while other factors did not attain significance.
Conclusion: Placenta accreta spectrum is not uncommon among women with pregnancies complicated by placenta praevia at the RSUTH. PAS occurred more among booked multiparous women with secondary level education and with an increasing trend. History of previous caesarean section is strongly associated with PAS.
References
2.Jauniaux E, Silver RM, Matsubara S. The new world of placenta accreta spectrum disorders. International Journal of Gynecology & Obstetrics. 2018;140:259-60.
3.Jauniaux E, Grønbeck L, Bunce C, Langhoff-Roos J, Collins SL. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ open. 2019;9:e031193.
4.Balachandar K, Melov SJ, Nayyar R. The risk of adverse maternal outcomes in cases of placenta praevia in an Australian population between 2007 and 2017. Australian and NewZealand Journal of Obstetrics and Gynaecology. 2020;60:890-5.
5.Fan D, Wu S, Liu L, Xia Q, Wang W, Guo X, et al. Prevalence of antepartum hemorrhage in women with placenta previa: a systematic review and meta-analysis. Scientific reports.2017;7:1-9.
6.Hobson SR, Kingdom JC, Murji A, Windrim RC, Carvalho JC, Singh SS, et al. No. 383-screening, diagnosis, and management of placenta accreta spectrum disorders. Journal ofObstetrics and Gynaecology Canada.2019;41:1035-49.
7.Paterson-Brown S, Draycott TJ. Obstetrics Emergencies. In: Edmonds K, Lees C, Bourne T, editors. Dewhurst's Texbook of Obstetrics and Gynaecology. Ninth ed. Hoboken, NJ John Wiley & Sons Ltd; 2018.
8.Jauniaux E, Ayresde-Campos D, Langhoff-Roos J, Fox KA, Collins S, Diagnosis FPA, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. International Journal of Gynecology& Obstetrics. 2019;146:20-4.
9.Fitzpatrick KE, Sellers S, Spark P, KurinczukJJ, BrocklehurstP, Knight M. Incidence and r isk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PloS one.2012;7:e52893.
10.Silver RM, Lyell DJ. Placenta accreta spectrum. Protocols for High? Risk Pregnancies: An Evidence? Based Approach.2020:571-80.
11.Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors forWekere FCC, et al -Placenta Accreta Spectrumplacenta accreta: a large prospective cohort.Americanjournalofperinatology.2014;31:799-804.
12.Thurn L, Lindqvist P, Jakobsson M, Colmorn L, Klungsoyr K, Bjarnadóttir RI, et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population? based pregnancy cohort study in the Nordic countries. BJOG: AnInternational Journal of Obstetrics & Gynaecology. 2016;123:1348-55.
13.Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Americanjournal of obstetrics andgynecology.2005;192:1458-61.
14.Bailit JL, Grobman W, Rice MM, Reddy UM, Wapner RJ, Varner MW, et al. Morbidly adherent placenta treatments and outcomes. Obstetrics and gynecology. 2015;125:683.
15.Umezurike C, Nkwocha G. Placenta accreta in Aba, south easternNigeria. Nigerian Journalof medicine. 2007;16:219-22.
16.Jauniaux E, Alfirevic Z, Bhide A, Belfort M, Burton G, Collins S, et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. BJOG.2018;126:e1-e48.
17.Wekere FCC, Kua PL, Akani A, Bademosi A. Prevalence, maternal and perinatal sequelae of antepartum haemorrhage in a tertiary hospital in South-South, Nigeria. International Journalof Clinical Obstetrics and Gynaecology.2021;5:206-10.
18.Badr DA, Al Hassan J, Wehbe GS, Ramadan MK. Uterine body placenta accreta spectrum: A detailed literature review. Placenta. 2020; 95:44-52.
19.Umezurike C, Feyi-Waboso P. Placenta accreta and the developing world-A review. EastAfrican Medical Journal. 2010;87:513-20.
20.Wekere FCC, Nonye-Enyidah EI, Kua PL. Ectopic pregnancy in Rivers State University Teaching Hospital, Port Harcourt, southern Nigeria: a five-year review. World Journal ofAdvanced Research and Reviews.2020;6:044-53.
21.Wekere FCC, Iwo-Amah RS, Kwosah JN, Bademosi A, Amadi CS. A Five-Year Review of Caesarean Section at the Rivers State University Teaching Hospital, South-South,
Nigeria. JAMMR. 2021;33:159-67.
22.Wekere FCC, Okagua KE, Clement-Wekere GA, Ocheche US, Mberekpe PO, Altriade BO, et al. Placenta Praevia in a Tertiary Hospital in Southern Nigeria: A Six-Year Review of Prevalence, Trend, and Risk Factors. International Journal ofMedical Science andClinical Research Studies. 2022;2:350-4.
23.Matsuzaki S, Mandelbaum RS, Sangara RN, McCarthy LE, Vestal NL, Klar M, et al. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States. American Journal of Obstetrics andGynecology. 2021;225:534. e1-. e38.
24.El Gelany S, Mosbeh MH, Ibrahim EM, Mohammed Mm, Khalifa EM, Abdelhakium AK, et al. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study. BMC pregnancy and childbirth.2019;19:1-8.
25.Asciooglu O,Sahbaz A, Güngördük K, Yildirim G, Ascioglu BB, Ülker V. Maternal and perinatal outcomes in women with placenta praevia and accreta in teaching hospitals in Western Turkey. Journal ofObstetrics and Gynaecology. 2014;34:462-6.
26.Prasanth S, Mehta P, Rajeshwari K. Maternal and fetal outcome of placenta previa in a tertiary care institute: a prospective two year study. Indian Journal of Obstetrics andGynecology Research. 2016;3:274-8.
27.Saleh S, Ismaeel SK. Placenta Previa: Risk Factors, Maternal andFetal Outcome-The Middle East Experience. Intl J Clin Diag Res.2018;6.
28.Wekere FCC, Iwo-Amah RS, Kwosah JN, Bademosi A, Amadi SC, Kua PL, et al. Caesarean Section at the Rivers State University Teaching Hospital, Southern Nigeria: A Five-year Review. New Horizons inMedicine and Medical Research9. 2022:44-53.
29.Ali H, Chandraharan E. Etiopathogenesis and risk factors for placental accreta spectrum disorders. Best Practice & Research Clinical Obstetrics & Gynaecology. 2021;72:4-12
30.Wekere FCC, et al -Placenta Accreta Spectrumplacenta accreta, placenta increta and placenta percreta in Peripartum hysterectomy specimens. Indian Journal of Pathology andMicrobiology. 2020;63:87.
31.Ornaghi S, Maraschini A, Donati S; Regional Obstetric Surveillance System Working Group.Characteristics and outcomes of pregnant women with placenta accretaspectrum in Italy: A prospective population-based cohort study. PloS One. 2021;16:e0252654.
32.Zakherah MS, Abdel-Aziz M, Othman ER, Abbas AM. Maternal and neonatal outcomes of placenta previa and accreta at Assiut women's health hospital, Egypt. International Journal ofReproduction, Contraception, Obstetrics and Gynecology. 2018;7:3024-9.
33.Kiliçci Ç, Eken MK, İlhan G, Çöğendez E, Şanverdi İ, Keskin M, et al. Evaluation of Risk Factors, Incidence, Perinatal and Maternal Outcome of Placenta Previa Cases with and without Placenta Accreta Spectrum.Duzce MedicalJournal. 2017;19:75-80
34.Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR, Obstetricians ACo, et al. Placenta accreta spectrum. American journal of obstetrics andgynecology. 2018;219:B2-B16.
35.Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. American journal ofobstetrics and gynecology. 2017;217:27-36.
36.Keag OE, Norman JE, Stock SJ. Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis. PLoS medicine.2018;15:e1002494.
37.Usta IM, Hobeika EM, Musa AAA, Gabriel GE, Nassar AH. Placenta previa-accreta: risk factors and complications. American journal ofobstetrics and gynecology. 2005;193:1045-9.
38.Dare F, Oboro V. Risk factors of placenta accreta in Ile-Ife, Nigeria. The NigerianPostgraduate Medical Journal. 2003;10:42-5.30.Heena AB, Kumari G. Retrospective study of
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.